Production (Stage)
BioAtla, Inc.
BCAB
$0.391
$0.00140.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.00% | 44.72% | 68.23% | 41.06% | 15.39% |
| Total Depreciation and Amortization | -23.75% | -38.04% | -15.56% | -21.03% | -18.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.22% | -58.98% | -37.62% | -32.08% | -36.36% |
| Change in Net Operating Assets | 91.10% | 46.75% | 38.26% | -111.00% | -1,227.25% |
| Cash from Operations | 47.16% | 43.91% | 81.23% | 20.34% | -36.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 6,150.34% | -100.00% | 41.04% | -- |
| Repurchase of Common Stock | -123.08% | 100.00% | 74.55% | 67.24% | 88.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,938.46% | 7,726.05% | 65.85% | 95.65% | 88.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.91% | 74.94% | 81.23% | 20.95% | -35.15% |